NEW IDEA ON HUMAN GENOME SCIENCES INC. (HGSI)

Twitter
LinkedIn
Facebook

This post was published earlier on ZYX Buy Change Alert

Last year  Human Genome Sciences Inc. (HGSI) successfully introduced the first new treatment for Lupus in a very long time.  GlaxoSmithKline (GSK), the big drug giant, is Human Genome’s partner.

Human Genome has disclosed that it received an unsolicited $13.00 per share cash offer from GlaxoSmithKline.

It is likely that the deal will ultimately get done at a premium to the present bid of $13.00 per share.

Buy zone is $12.50 to $13.56.  To control risk consider not exceeding 20% of full core position size.  Stop zone is$11.48 to  $11.75.  Target zone is $16 to $18.

Caution:  Consider not chasing the price even at the risk of missing the trade.  Further it is important to keep the position small because of the risk involved.  There is no guarantee that a deal will done.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence